Learn More
ATCC RPMI 2650; Nasal Septum Carcinoma; Human (Homo sapiens)
Supplier: ATCC CCL30

RPMI 2650 is a cell line exhibiting epithelial morphology from the nasal septum of a 52-year-old, male patient with squamous cell carcinoma. This cell line was deposited by GE Moore and can be used in cancer research, and toxicology.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.